1 active not recruiting, 1 completed, 1 recruiting, 1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Active not recruiting 1 |
Follow Adenoma, Oxyphilic: new trials by email Literature Review of Adenoma, Oxyphilic trials Research Report on Adenoma, Oxyphilic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Renal Cancer Detection With Liquid Biopsy GaGnostic - Renal Cancer, Oncocytoma | Recruiting | Zealand University Hospital | 200 | 2021-07-01 | 2024-01-30 | |
| PDR001 Combination Therapy for Radioiodine-Refractory Thyroid Cancer Trametinib, Dabrafenib, PDR001 - Thyroid Cancer, Thyroid Cancer, Follicular | Phase 2 | Active not recruiting | Memorial Sloan Kettering Cancer Center | 19 | 2020-09-02 | 2026-09-17 |
| Biomarkers of Renal Cancer Renal Cell Carcinoma, Tumor, Solid | Unknown | Biorek S.R.L. | 1000 | 2019-06-11 | 2023-03-27 | |
| Genetic Analysis of Inherited Urologic Malignant Disorders: Collection of Samples Neoplastic Syndromes, Hereditary, Urologic Neoplasms | Completed | National Cancer Institute (NCI) | 600 | 1999-04-01 | 2008-03-04 |
Adenocarcinoma, Follicular (1) · Angiomyolipoma (1) · Carcinoma, Renal Cell (1) · Kidney Neoplasms (1) · Neoplasms (1) · Neoplastic Syndromes, Hereditary (1) · Thyroid Cancer, Papillary (1) · Thyroid Neoplasms (1) · Thyroid cancer, Hurthle cell (1) · Thyroid cancer, follicular (1) · Urologic Neoplasms (1)
Adenoma (4) · Neoplasms by Histologic Type (4) · Neoplasms by Site (4) · Neoplasms, Glandular and Epithelial (4) · Female Urogenital Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3) · Male Urogenital Diseases (3) · Neoplasms (3) · Urogenital Diseases (3) · Urogenital Neoplasms (3) · Urologic Diseases (3) · Adenocarcinoma (2) · Carcinoma (2) · Kidney Diseases (2) · Urologic Neoplasms (2)
dabrafenib (1) · spartalizumab (1) · trametinib (1)
Biorek S.R.L. (1) · Memorial Sloan Kettering Cancer Center (1) · National Cancer Institute (NCI) (1) · Zealand University Hospital (1)
United States (2) · Denmark (1) · Italy (1) · Spain (1)
Alan L Ho, MD, PhD (1) · Francesco Montorsi (1)